RxDoctor Payments Data

Elizabeth Bell, APRN

Family · Virginia Beach, VANPI 1306257902

Payments from drug & device makers

$822in general payments, 2019–2025

Across 46 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$95
  • AbbVie$88
  • GSK$86
  • Phathom Pharmaceuticals, Inc.$83
  • Lundbeck LLC$76
  • Lilly USA, LLC$74
  • plus $321 from 12 others

What the payments were for

  • Food & beverage$822100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$822 in reported general payments places this provider in the 65th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$37,468
Medicare patients
276
Services billed
1,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,174
Doxycycline Hyclate52$894
Albuterol Sulfate HfaAlbuterol Sulfate32$813
Gabapentin51$558
Losartan Potassium52$548
Atorvastatin Calcium50$518
Fluticasone Propionate32$372
Omeprazole21$333
Rosuvastatin Calcium11$326
Methocarbamol15$275
Famotidine29$240
Lisinopril16$225
Levothyroxine Sodium29$197
Pantoprazole Sodium11$185
Mupirocin25$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$86$18,17427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,332 family providers in Virginia.

Other family in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →